VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by GrahamBon Nov 05, 2024 8:42am

32 Views

Post# 36296692

Insider Sales

Filed 2024-11-04 19:54 Tx date 2024-10-31	$VPT Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)	Hugo, Victor Johan 5 - Senior Officer of Issuer Holder: Tableview Capital Inc. (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-7,575 -50,500 vol $0.15 each	32,656

Source:Insider sales.com

Insiders buy and sell for many reasons.
Just a FYI for those who follow the stock.

DYODD
Not provided to inform on whether to buy/sell.
Its for education, mostly mine
Speak to your advisor before buying or selling finacial products.

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1